Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
Miriam Echaide, Luisa Chocarro, Ana Bocanegra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5944-5944
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Innovations in RNA therapeutics: a review of recent advances and emerging technologies
Tuward J. Dweh, Glay Jr Eric Wulu, John Kessellie Jallah, et al.
Nucleosides Nucleotides & Nucleic Acids (2025), pp. 1-25
Closed Access | Times Cited: 2
The Role of Memory T-Cell Mediated Immunity in Long-term COVID-19: Effects of Vaccination Status.
Saulesh Kurmangaliyeva, Akzhan M. Madenbayeva, Saltanat T. Urazayeva, et al.
PubMed (2025) Vol. 50, Iss. 2, pp. 61-68
Closed Access | Times Cited: 2
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 14
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
COVID-19 Vaccines: Where Did We Stand at the End of 2023?
Kenneth Lundström
Viruses (2024) Vol. 16, Iss. 2, pp. 203-203
Open Access | Times Cited: 10
S6P mutation in Delta and Omicron variant spike protein significantly enhances the efficacy of mRNA COVID-19 vaccines
Yong‐Sik Bong, David Alan Brown, Ezra Chung, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Enhanced stability and efficacy of a lyophilized mRNA SARS-CoV-2 vaccine incorporating novel Ionizable lipids after one year storage at 25ºC
Elena Mata, Esther Broset, Carlos Matute, et al.
Research Square (Research Square) (2025)
Closed Access | Times Cited: 1
Clinical development of SpikoGen®, an Advax-CpG55.2 adjuvanted recombinant spike protein vaccine
Nikolai Petrovsky
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Serosurveillance among urban slum and non-slum population immunized with COVID-19 vaccines in Bangladesh
Protim Sarker, Md. Ahsanul Haq, Evana Akhtar, et al.
Epidemiology and Infection (2024), pp. 1-34
Open Access | Times Cited: 6
Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19
Shehzad Iqbal, Andrew M. Rosen, Darin K. Edwards, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 6
RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
Mohammad Natami, Amirsasan Gorgzadeh, Arsalan Gholipour, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Dissecting the Protective Effect of CD8+ T Cells in Response to SARS-CoV-2 mRNA Vaccination and the Potential Link with Lymph Node CD8+ T Cells
Mengfei Chen, Vanessa Venturi, C. Mee Ling Munier
Biology (2023) Vol. 12, Iss. 7, pp. 1035-1035
Open Access | Times Cited: 11
Immune responses in COVID-19 patients: Insights into cytokine storms and adaptive immunity kinetics
J Zhang
Heliyon (2024) Vol. 10, Iss. 14, pp. e34577-e34577
Open Access | Times Cited: 4
Advancement in the development of mRNA‐based vaccines for respiratory viruses
Tays Troncoso‐Bravo, Mario A. Ramírez, Ricardo A. Loaiza, et al.
Immunology (2024) Vol. 173, Iss. 3, pp. 481-496
Open Access | Times Cited: 4
Designing novel multiepitope mRNA vaccine targeting Hendra virus (HeV): An integrative approach utilizing immunoinformatics, reverse vaccinology, and molecular dynamics simulation
Ahmad Abdullah Mahdeen, Imam Hossain, Md. Habib Ullah Masum, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0312239-e0312239
Open Access | Times Cited: 4
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens
Matteo Ridelfi, Giulio Pierleoni, V. Fonseca, et al.
Seminars in Respiratory and Critical Care Medicine (2025)
Closed Access
Avian influenza mRNA vaccine encoding hemagglutinin provides complete protection against divergent H5N1 viruses in specific-pathogen-free chickens
Zhaoyang Wang, Chongyu Tian, J. ZHU, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Sequences in the Cytoplasmic Tail Contribute to the Intracellular Trafficking and the Cell Surface Localization of SARS-CoV-2 Spike Protein
Evgeniya E. Burkova, Irina A. Bakhno
Biomolecules (2025) Vol. 15, Iss. 2, pp. 280-280
Open Access
Inhaled non-viral delivery systems for RNA therapeutics
Cheng Huang, Hongjian Li, Xing Duan, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Generation of an inflammatory niche in a hydrogel depot through recruitment of key immune cells improves efficacy of mRNA vaccines
Emily L. Meany, John H. Klich, Carolyn K. Jons, et al.
Science Advances (2025) Vol. 11, Iss. 15
Open Access
From in vitro to in Vivo: The Dominant role of PEG-Lipids in LNP performance
Ankita Borah, Valeria Giacobbo, Burcu Binici, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2025), pp. 114726-114726
Closed Access
Main and papain-like proteases as prospective targets for pharmacological treatment of coronavirus SARS-CoV-2
Larysa V. Yevsieieva, Kateryna Lohachova, Alexander Kyrychenko, et al.
RSC Advances (2023) Vol. 13, Iss. 50, pp. 35500-35524
Open Access | Times Cited: 10
Intranasal administration of unadjuvanted SARS‐CoV‐2 spike antigen boosts antigen‐specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters
Gerard Agbayani, Bassel Akache, Tyler M. Renner, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 6
Open Access | Times Cited: 3
Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2
Jingbo Huang, Weiqi Wang, Hailun Li, et al.
Antiviral Research (2024) Vol. 227, pp. 105905-105905
Closed Access | Times Cited: 3
Cytokine Storm in COVID-19: Insight into Pathological Mechanisms and Therapeutic Benefits of Chinese Herbal Medicines
Qingyuan Yu, Xian Zhou, Rotina Kapini, et al.
Medicines (2024) Vol. 11, Iss. 7, pp. 14-14
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top